To modify or not to modify—That is still the question for some mRNA applications
Saved in:
| Main Authors: | Sofía Soler, Katharina Maser, Thomas Zillinger, Eva Bartok |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253125002094 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons
by: Liangzhen Dong, et al.
Published: (2025-08-01) -
mRNA EXPRESSION OF SOME CHEMOKINES AND THEIR RECEPTORS IN NASAL MUCOSA OF HEALTHY PERSONS
by: A. A. Bibkova, et al.
Published: (2014-07-01) -
Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19
by: Adewunmi Akingbola, et al.
Published: (2025-05-01) -
Unraveling the potential: mRNA therapeutics in oncology
by: Karol Gawalski, et al.
Published: (2025-08-01) -
Quantifying the phenotypic information in mRNA abundance
by: Evan Maltz, et al.
Published: (2022-08-01)